These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37149563)

  • 1. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.
    Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH
    BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
    Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
    Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient Prognosis Based on TCGA and GTEx Databases.
    Liao Y; Liu B; Jin C; Liao X; Zhang Z
    J Mol Neurosci; 2022 Dec; 72(12):2413-2424. PubMed ID: 36449138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.
    Li Q; Shen K; Zhao Y; Ma C; Liu J; Ma J
    J Transl Med; 2013 Dec; 11():302. PubMed ID: 24325785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway.
    Xu J; Su Z; Ding Q; Shen L; Nie X; Pan X; Yan A; Yan R; Zhou Y; Li L; Lu B
    Oncol Res; 2019 Jul; 27(7):819-826. PubMed ID: 30940290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma.
    Zhong WJ; Zhang LZ; Yue F; Yuan L; Zhang Q; Li X; Lin L
    Cancer Biomark; 2024; 40(3-4):297-317. PubMed ID: 39213054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the circadian clock network correlates with tumour progression in gliomas.
    Petkovic M; Yalçin M; Heese O; Relógio A
    BMC Med Genomics; 2023 Jul; 16(1):154. PubMed ID: 37400829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
    Biterge-Sut B
    Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis.
    Qin J; Fu J; Chen X
    J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
    Karunasena E; McIver LJ; Rood BR; Wu X; Zhu H; Bavarva JH; Garner HR
    Oncotarget; 2014 Aug; 5(15):6003-14. PubMed ID: 25153720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.